Dr. Hojun Li

Charles W (1955) and Jennifer C Johnson Clinical Investigator

Primary DLC

Koch Institute for Integrative Cancer Research (KIICR)

MIT Room: 76-361F

Areas of Interest and Expertise

Personalized Medicine

Research Summary

Dr. Li’s research at the Koch Institute remains focused on basic hematopoietic stem and progenitor cell biology in both the physiologic and pathologic settings. He aims to develop clinically relevant approaches for both small molecule intervention in leukemia predisposition syndromes, and genetic correction of hematopoietic stem cells.

Recent Work